Machine Learning Blood Test Detects Cancers with Genome-Wide Mutations in Single Molecules of Cell-Free DNA

Novel blood testing technology being developed by researchers at the Johns Hopkins Kimmel Cancer Center that combines genome-wide sequencing of single molecules of DNA shed from tumors and machine learning may allow earlier detection of lung and othe

Related Keywords

Daniel Bruhm ,Vilmos Adleff ,James White ,Valsamo Anagnostou ,Rob Scharpf ,Jamie Medina ,Jillian Phallen ,Dimitrios Mathios ,Victor Velculescu ,Stephen Cristiano ,Zachariah Foda ,Johns Hopkins ,Resphera Biosciences ,Leonardo Ferreira ,Akshaya Annapragada ,Ramy Kim ,Johns Hopkins Kimmel Cancer Center ,Boston University ,Mark Foundation For Cancer Research ,Gray Foundation ,Allegheny Health Network Cancer Institute In Pittsburgh ,Us National Institutes Of Health ,Icole Foundation ,Commonwealth Foundation ,Johns Hopkins University ,Sheldong Adelson Medical Research Foundation ,Johns Hopkins University School Of Medicine ,Kimmel Cancer Center ,Genome Wide Mutational Incidence ,Kimmel Cancer ,Johns Hopkins University School ,Pan Cancer Analysis ,Whole Genomes ,Elaine Jiayuee Chiao ,Allegheny Health Network Cancer Institute ,Medical Research Foundation ,Mark Foundation ,Cancer Research ,Delfi Diagnostics ,Viron Therapeutics ,